Respiratory Syncytial Virus Rsv Infection clinical trials

Explore recruiting respiratory syncytial virus rsv infection clinical trials.

Recruiting respiratory syncytial virus rsv infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Syncytial Virus Rsv Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

C5241009 - An interventional, Phase 1b, randomized, double-blind, sponsor-open, placebo-controlled, multi-center, dose-finding study to evaluate safety, tolerability and pharmacokinetics of sisunatovir in pediatric participants up to age 60 months with Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Infection (LRTI)

Spain, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection Using Wharton’s Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans®): open Phase IB Clinical Trial

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease

Germany, Spain, Hungary, Finland, France, Norway +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Respiratory Syncytial Virus Rsv Infection trials by city

Respiratory Syncytial Virus Rsv Infection in Toronto Respiratory Syncytial Virus Rsv Infection in Vancouver Respiratory Syncytial Virus Rsv Infection in Montreal Respiratory Syncytial Virus Rsv Infection in Calgary Respiratory Syncytial Virus Rsv Infection in Edmonton Respiratory Syncytial Virus Rsv Infection in Ottawa Respiratory Syncytial Virus Rsv Infection in Winnipeg Respiratory Syncytial Virus Rsv Infection in Quebec City Respiratory Syncytial Virus Rsv Infection in Hamilton Respiratory Syncytial Virus Rsv Infection in Kitchener Respiratory Syncytial Virus Rsv Infection in London Respiratory Syncytial Virus Rsv Infection in Halifax Respiratory Syncytial Virus Rsv Infection in New York Respiratory Syncytial Virus Rsv Infection in Los Angeles Respiratory Syncytial Virus Rsv Infection in Chicago Respiratory Syncytial Virus Rsv Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease